Erlotinib vs Levodopa

Erlotinib vs Levodopa: Overview

This comparison examines the pharmacological differences between Erlotinib and Levodopa.

Mechanism of Action

Erlotinib: Reversible inhibitor of EGFR (HER1) tyrosine kinase, blocking autophosphorylation.

Levodopa: Metabolic precursor of dopamine that crosses the BBB.

Pharmacokinetics

Half-life: Erlotinib — 36 hours; Levodopa — 1.5 hours.

Chemical Properties

Molecular Formula: Erlotinib — C22H23N3O4; Levodopa — C9H11NO4.

Molecular Weight: Erlotinib — 393.4380 g/mol; Levodopa — 197.1880 g/mol.

Type: Erlotinib — Small molecule; Levodopa — Small molecule.